Proposed Updates to Animal-Derived Food Processing Enterprise Information Reporting Regulations in the United States
In a recent announcement, the United States Food Safety and Inspection Service (FSIS) revealed its intention to update the regulations governing the reporting of information by animal-derived food processing enterprises. This move aims to enhance the safety and transparency of the food industry. The proposed revisions include requirements for record-keeping, information submission, and collaboration with relevant government agencies.
Key Points:
On April 15, 2024, the FSIS issued Notice 2024-07996, outlining the proposed updates to the regulations governing animal-derived food processing enterprise information reporting. The main revisions are as follows:
1. Mandatory Information Submission: Meat, poultry, game, and rabbit meat production and processing enterprises would be required to maintain key information, including production records. They would also need to submit relevant information to the FSIS through the public health information system. Specifically, poultry processing enterprises must complete FSIS Form 6510-7 for each production batch and submit it to the FSIS after the production process concludes.
2. Official Inspections and Reporting: Based on the information submitted by enterprises, the FSIS would conduct official inspections, develop official sampling plans, and compile annual reports and budgets. Additionally, the FSIS would share relevant meat industry information and data with other agencies under the United States Department of Agriculture, such as the Animal and Plant Health Inspection Service (APHIS) and the Agricultural Marketing Service (AMS).
Feedback and Implementation:
The proposed updates are scheduled to be officially published in the Federal Register on April 16, 2024. Stakeholders and interested parties will have a 60-day feedback period to provide their comments and suggestions on the proposed regulations. Following the feedback period, the FSIS will consider the input received and make any necessary adjustments before finalizing the updated regulations.
The proposed updates to the animal-derived food processing enterprise information reporting regulations in the United States aim to improve the safety and transparency of the food industry. By requiring information submission and collaboration with government agencies, these regulations seek to enhance oversight and ensure the production and processing of animal-derived foods meet established standards. As the feedback period commences, industry stakeholders and interested parties will have the opportunity to contribute their perspectives and help shape the final regulations that will govern this critical aspect of the food industry in the United States.
2026-10-21
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
MENA Pharmaceutical Regulatory Updates 2026: Key Compliance Changes for Global Pharma Companies
-
FDA approves bemotrizinol, a long-used UV filter, for U.S. sunscreens
-
US Pushes G20 to Reassess Trade with China, Raising New Risks for Chemical Exporters
-
GM Crop Area Reaches 216 Million Hectares
-
GM Crop Area Reaches 216 Million Hectares
-
FDA Delays Beetroot Red and Spirulina Color Orders
-
Sudden Turmoil in Middle East Shipping Routes: Multiple Carriers Announce Emergency Navigation and Surcharge Policies
-
FDA Pushes New Approach to “No Artificial Colors” Claims
-
WACKER’s 2025 Loss Reaches €805 Million as the PACE Cost-Cutting Plan Becomes the Key Variable for 2026
-
EU Chemicals Regulatory Update: Practical Compliance Actions Following ECHA January 2026 Developments
Recommend Reading
-
Four Fine Chemical Units of Huajin Aramco Project – HDPE, EO/EG, etc. – Reach Mechanical Completion
-
关于将二氟乙咪酯等16种物质列入《非药用类麻醉药品和精神药品目录》的公告 Announcement on the Inclusion of 16 Substances including Difluoroetomidate in the Catalogue of Non-Medicinal Narcotic Drugs and Psychotropic Substances
-
U.S. Section 232 Pharmaceutical Tariffs Take Effect, With 100% Base Rate on Patented Drugs and APIs
-
U.S. and China Reach Consensus on More Favorable Tariff Treatment for $30 Billion of Goods Each Way
-
Vera’s New Kidney Drug Wins FDA Approval, Carrying a $425,000 Annual Price
-
May China Gasoline and Diesel Market Trends Show Volatility
-
Business Society September 24, 2026 Palm Oil Trend Analysis: Clear Decline
-
This week, China's 180CST fuel oil market trend is downward
-
Business Society October 19, 2026 Hydrogen Peroxide Trend Analysis: Volatility
-
Business Society October 19, 2026 Lithium Carbonate Trend Analysis: Volatility